4:07 PM
Jan 22, 2019
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Cardiomyopathy

Patient sample studies suggest CRISPR-mediated editing of the B isoform of LAMP2 could help treat Danon disease, a cardiomyopathy caused by a loss-of-function...

Read the full 100 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >